Anlotinib Combined with Cranial Radiotherapy Shows Promise for Lung Cancer Brain Metastases
A narrative review evaluates how combining the multitarget tyrosine kinase inhibitor anlotinib with cranial radiotherapy may improve intracranial disease control ...










